Pharmaceutical executive who drove up the price of HIV drug sentenced to 3 years in prison

Mar 10, 2018, 15:11 IST | ANI

Former drug firm executive Martin Shkreli, who drove up the price of drug used to treat HIV by 50 times, has been sentenced seven-year imprisonment by a New York federal court for defrauding investor

Representation pic

Former drug firm executive Martin Shkreli, who drove up the price of drug used to treat HIV by 50 times, has been sentenced seven-year imprisonment by a New York federal court for defrauding investor. The 'Pharma Bro' was convicted last year for defrauding investors by showing fake account statements of two failing hedge funds that he ran.

The 34-year-old pharmaceutical executive, who has gained notoriety for driving up the price of HIV drug in 2015 and trolling critics online, cried in the court and apologised to investors, according to the PBS. 'I am terribly sorry I lost your trust,' he reportedly said in the court. 'You deserve far better.' Though his lawyers pleaded for leniency in sentencing, the U.S. District Judge Kiyo Matsumoto termed his crimes serious and handed him the sentence.

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

Trending Video

Tags

world news

DISCLAIMER: mid-day and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Ganesh Chaturthi 2018: 5 injured after boat flips at Girgaon Chowpatty

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK